Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients

NCT02282709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Daclatasvir
DRUG: asunaprevir

Sponsor

Foundation for Liver Research